Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Díaz-Llopis M, Salom D, Garcia-de-Vicuña C, Cordero-Coma M, Ortega G, Ortego N, Suarez-de-Figueroa M, Rio-Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez-Del-Castillo JM, Olea JL, Arevalo JF. Díaz-Llopis M, et al. Ophthalmology. 2012 Aug;119(8):1575-81. doi: 10.1016/j.ophtha.2012.02.018. Epub 2012 Apr 21. Ophthalmology. 2012. PMID: 22525047
Anti-tumor necrosis factor-α therapy in uveitis.
Cordero-Coma M, Sobrin L. Cordero-Coma M, et al. Surv Ophthalmol. 2015 Nov-Dec;60(6):575-89. doi: 10.1016/j.survophthal.2015.06.004. Epub 2015 Jul 9. Surv Ophthalmol. 2015. PMID: 26164735 Review.
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.
Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, Salom D, Ortego N, García-Serrano JL, Callejas-Rubio JL, Herreras JM, García-Aparicio Á, Maíz O, Blanco A, Torre I, Díaz-Valle D, Pato E, Aurrecoechea E, Caracuel MA, Gamero F, Minguez E, Carrasco-Cubero C, Olive A, Vázquez J, Ruiz-Moreno O, Manero J, Muñoz-Fernández S, Martinez MG, Rubio-Romero E, Toyos-Sáenz de Miera FJ, López Longo FJ, Nolla JM, Revenga M, González-Vela C, Loricera J, Atienza-Mateo B, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R. Martín-Varillas JL, et al. Ophthalmology. 2018 Sep;125(9):1444-1451. doi: 10.1016/j.ophtha.2018.02.020. Epub 2018 Mar 27. Ophthalmology. 2018. PMID: 29602570 Free article. Clinical Trial.
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.
Llorenç V, Cordero-Coma M, Blanco-Esteban A, Heras-Mulero H, Losada-Castillo MJ, Jovani-Casano V, Valls-Pascual E, Jodar-Marquez M, García-Aparicio Á, Fonollosa A, González-Guijarro JJ, Rodriguez-Melian L, Fernández-Prada M, Jerez-Fidalgo M, Hernandez-Garfella M, Esquinas C, Sainz-de-la-Maza M, Adán A; Biotherapies in Uveitis (BioÚvea) Study Group. Llorenç V, et al. Ophthalmology. 2020 Jun;127(6):814-825. doi: 10.1016/j.ophtha.2019.11.024. Epub 2019 Dec 2. Ophthalmology. 2020. PMID: 31952883 Free article.
88 results